ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0540

Behavioral Deficits May Precede Influx of Brain-Infiltrating Macrophages in Neuropsychiatric Symptoms of Systemic Lupus Erythematosus

Hadijat Makinde, Miranda Gurra, Yidan Wang, Sara Radecki and Carla Cuda, Northwestern University, Chicago, IL

Meeting: ACR Convergence 2021

Keywords: macrophages, microglia, Mouse Models, Lupus, neuropsychiatric disorders, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: SLE – Animal Models Poster (0534–0540)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Systemic lupus erythematosus (SLE) is a complex autoimmune disease that affects many end organs including the brain. Despite a prevalence of over 50% in SLE patients depending on the attribution model, neuropsychiatric symptoms of SLE (NPSLE), including anxiety and movement disorders, are among the least understood complications. Notwithstanding the paucity of data examining underlying mechanisms, accumulating evidence points to microglia, the resident innate immune cells in the brain, as a driver of disease. The cross-talk between infiltrating monocyte-derived macrophages and microglia plays a critical role in directing microglial responses. However, the question remains whether macrophage infiltration precedes NPSLE manifestations. Here, we longitudinally investigate macrophage infiltration into the brain in two models of SLE.

Methods: B6 and SLE-prone B6.Sle1Sle2Sle3 (B6.TC; Jackson #007228) mice underwent a battery of behavioral tasks at 2 months of age. Spleen and cervical lymph nodes were weighed as an indicator of systemic disease from female B6 and B6.TC mice spanning disease progression (n=3-5/timepoint; 2, 5, 8, 11 months of age). At each timepoint, brains were perfused and extracted, meninges were removed and live CD45+CD11b+ cells were FACSorted from pooled cell suspensions (n=3/strain/timepoint to account for biological variability) for single-cell RNA-seq (10X Genomics 3’ v3.1) in conjunction with cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq); analysis pending. Two additional cohorts of B6 and B6.TC mice were evaluated for brain microglia infiltration and microglial distribution via flow cytometry at 11 months of age. NPSLE-prone CReCOM mice showed behavioral deficits at 3 months of age and underwent longitudinal analyses described above.

Results: Similar to patients with NPSLE, B6.TC mice exhibited heightened anxiety, impaired motor coordination and locomotive deficits compared to control mice, suggesting B6.TC mice are a valid model for NPSLE-associated symptoms. NPSLE-prone mice showed an age-dependent increase in splenomegaly and lymphadenopathy. At 11 months of age, microglia were expanded in NPSLE-prone mice compared to their respective controls, including the recently discovered disease-associated microglia subset associated with neurodegenerative disease. Further, there was an age-dependent increase in the number of brain-infiltrating macrophages in NPSLE-prone mice. However, levels of brain-infiltrating macrophages were comparable to levels in control mice at 2 months of age, indicating that macrophage infiltration occurs between 2 and 5 months of age in NPSLE-prone mice.

Conclusion: As macrophage levels in the brains of NPSLE-prone mice are comparable to control levels at 2 months of age but behavioral deficits occur at 2-3 months of age in NPSLE-prone mice, we provide the first evidence that macrophage infiltration may be a response to NPSLE-like disease incited by brain-intrinsic mechanisms rather than a cause. Future studies will identify the exact timing of macrophage infiltration to define their role as either disease initiators or responders and dissect macrophage heterogeneity during NPSLE progression.


Disclosures: H. Makinde, None; M. Gurra, None; Y. Wang, None; S. Radecki, None; C. Cuda, None.

To cite this abstract in AMA style:

Makinde H, Gurra M, Wang Y, Radecki S, Cuda C. Behavioral Deficits May Precede Influx of Brain-Infiltrating Macrophages in Neuropsychiatric Symptoms of Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/behavioral-deficits-may-precede-influx-of-brain-infiltrating-macrophages-in-neuropsychiatric-symptoms-of-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/behavioral-deficits-may-precede-influx-of-brain-infiltrating-macrophages-in-neuropsychiatric-symptoms-of-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology